"FDA officials, who disclosed the HHS decision on Thursday, also said that Janet Woodcock, the director of the Center for Drug Evaluation and Research, had voluntarily withdrawn in August from a drug approval process involving Momenta Pharmaceuticals Inc., of Cambridge, Mass., and Amphastar Pharmaceuticals Inc. of Rancho Cucamonga, Calif."
Market Data 
Markets 
AI
